Hollow‐structured nanomaterials (HSNMs) have attracted increased interest in biomedical
fields, owing to their excellent potential as drug delivery systems (DDSs) for clinical …

Cancer is the second most frequent cause of death worldwide, with 28.4 million new cases
expected for 2040. Despite de advances in the treatment, it remains a challenge because of …

Lung cancer is the second most common type of cancer after breast cancer. It ranks first in
terms of mortality rate among all types of cancer. Lung cancer therapies are still being …

Cancer immunotherapy, which harnesses the immune system to fight cancer, has begun to
make a breakthrough in clinical applications. Dendritic cells (DCs) are the bridge linking …

The use of nanoparticles as carriers is an extremely promising way for administration of
therapeutic agents, such as drug molecules, proteins, and nucleic acids. Such nanocarriers …

Proteins have emerged as promising therapeutics in oncology due to their great specificity.
Many treatment strategies are developed based on protein biologics, such as …

Novel therapeutic agents in clinical trials offer a paradigm shift in the approach to battling
this prevalent and destructive disease, and the area of cancer therapy is on the precipice of …

Immunotherapy has revolutionized the modality for establishing a firm immune response
and immunological memory. However, intrinsic limitations of conventional low responsive …

The use of nanoparticles as carriers to deliver pharmacologically active compounds to
specific parts of the body via the bloodstream is a promising therapeutic approach for the …

The aim of this work was to evaluate the physicochemical and biological properties of
docetaxel (DCX) loaded chitosan nanocapsules (CS Nc) functionalized with the monoclonal …